Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 9 medicines
ALIMS · 8 medicines
EMA · 7 medicines
CBG-MEB · 7 medicines
SFDA · 7 medicines · Historical list
FDA · 7 medicines
MS · 5 medicines · Historical list
HSA · 5 medicines
AIFA · 4 medicines
PHARMAC · 1 medicine
TFDA · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
84 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Inflectra | United States | 100MG | injectable | Marketed | Celltrion INC |
| Bio Manguinhos Infliximabe | Brazil | Authorised | Fundação Oswaldo Cruz | ||
| Ixifi | United States | 100MG/VIAL | injectable | Marketed | Pfizer INC |
| Remicade | United States | 100MG | vial | Marketed | Centocor INC |
| Renflexis | United States | 100MG | injectable | Marketed | Samsung Bioepis Co LTD |
| Avsola | United States | 100MG/VIAL | injectable | Marketed | Amgen INC |
| Zymfentra | United States | 120MG/ML | injectable | Marketed | Celltrion |
| Zymfentra | United States | 120MG/ML | Injection | Marketed | CELLTRION, Inc. |
| Inflectra | European Union | Authorised | Pfizer Europe MA EEIG | ||
| Flixabi | European Union | Authorised | Samsung Bioepis NL B.V. | ||
| Flixabi | Italy | Polvere per concentrato per soluzione per infusione | Authorised | Samsung Bioepis NL B.V. | |
| Remsima | European Union | Authorised | Celltrion Healthcare Hungary Kft. | ||
| Remsima 120 MG Solucion Inyectable en Pluma Precargada | Spain | 120 mg/ml | solución inyectable en pluma precargada | Marketed | Celltrion Healthcare Hungary Kft. |
| Ixifi | Canada | 100 MG / VIAL | Powder For Solution | Marketed | Pfizer Canada Ulc |
| Flixabi 100MG Polvo Para Concentrado Para Solucion Para Perfusion | Spain | 100.00 mg | polvo para concentrado para solución para perfusión | Marketed | Samsung Bioepis Nl B.V. |
| Flixabi 100 mg, poeder voor concentraat voor oplossing voor infusie | Netherlands | Poeder voor concentraat voor oplossing voor infusie | Authorised | Samsung Bioepis NL B.V. | |
| Remsima 40 mg/ml concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Celltrion Healthcare Hungary Kft. | |
| Remsima 40 MG/ML Concentrado Para Solucion Para Perfusion | Spain | 40 mg/ml | concentrado para solución para perfusión | Marketed | Celltrion Healthcare Hungary Kft. |
| Remsima 100 MG Polvo Para Concentrado Para Solucion Para Perfusion | Spain | 100 mg | polvo para concentrado para solución para perfusión | Marketed | Celltrion Healthcare Hungary Kft. |
| Remsima 100 mg, poeder voor concentraat voor oplossing voor infusie | Netherlands | Poeder voor concentraat voor oplossing voor infusie | Authorised | Celltrion Healthcare Hungary Kft. | |
| Remicade 100 mg, poeder voor oplossing voor infusie | Netherlands | Poeder voor oplossing voor infusie | Authorised | Janssen-Cilag International NV | |
| Remsima | Italy | Concentrato per soluzione per infusione | Authorised | Celltrion Healthcare Hungary KFT | |
| Remicade | European Union | Authorised | Janssen Cilag International NV | ||
| Remicade 100 MG Polvo Para Concentrado Para Solucion Para Perfusion | Spain | 100 mg | polvo para concentrado para solución para perfusión | Marketed | Janssen-Cilag International N.V |
| Zessly | European Union | Authorised | Sandoz GmbH |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
